Login to Your Account

U.S. CoC challenges EMA on data transparency

By Nuala Moran
Staff Writer

Tuesday, June 10, 2014
As the EMA management board faces up to a crunch meeting on Thursday this week at which it is due to finally decide its clinical trials data transparency rules, the U.S. Chamber of Commerce (CoC) has challenged its approach in a critical report that said the proposed policy calls into question the agency's attitudes to the "inherent confidentiality" of data submitted in marketing applications and its role as a custodian of the information.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription